I’m as hopeful as all the CYDY investors that BT
Post# of 148187
I don’t remember if it was this board or another, but I recall a discussion regarding BTD filing and companies talking to the FDA about the packet prior to the application. Obviously the key opinion leaders in CYDY, including a couple of distinguished doctors in the cancer field, agreed with NP that BTD for cancer should be filed, even with only data from 2 patients. But based on information I’ve read before, it’s possible CYDY has exchanged emails or had a discussion with the FDA about their data and the BTD application.